XOMA Royalty Corporation (XOMAP) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for XOMA Royalty Corporation (XOMAP).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $26.48

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $401,815,757

Daily Volume: 0

Performance Metrics

1 Week: 1.61%

1 Month: 2.79%

3 Months: 0.11%

6 Months: 1.23%

1 Year: 3.43%

YTD: -2.33%

Company Details

Employees: 14

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Selected stocks

Vanda Pharmaceuticals Inc. (VNDA)

Jasper Therapeutics, Inc. (JSPR)

EDAP TMS S.A. (EDAP)